2,4,6-Tris(1-aziridinyl)-s-triazine.
D000818:Animals; D001388:Aziridines / Q000378:metabolism / Q000633:toxicity*; D001389:Azirines / Q000633:toxicity*; D002273:Carcinogens; D002869:Chromosome Aberrations; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007928:Lethal Dose 50; D007945:Leukemia, Lymphoid / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced; D010212:Papilloma / Q000139:chemically induced; D051381:Rats; D012878:Skin Neoplasms / Q000139:chemically induced; D014227:Triazines / Q000378:metabolism / Q000633:toxicity*
D001388:Aziridines; D001389:Azirines; D002273:Carcinogens; D014227:Triazines